Skip to main content

A different role for FDG PET/CT in axillary lymph node staging in breast cancer

European Journal of Nuclear Medicine and Molecular Imaging volume 36, Article number: 1896 (2009) Cite this article

This is a preview of subscription content, access via your institution.

Access options

Buy single article

Instant access to the full article PDF.

43,34 €

Price includes VAT (Finland)
Tax calculation will be finalised during checkout.

References

  1. Heusner TA, Kuemmel S, Hahn S, Koeninger A, Otterbach F, Hamami ME, et al. Diagnostic value of full-dose FDG PET/CT for axillary lymph node staging in breast cancer patients. Eur J Nucl Med Mol Imaging 2009. doi: 10.1007/s00259-009-1145-6.

  2. Fuster D, Duch J, Paredes P, Velasco M, Munoz M, Santamaria G, et al. Preoperative staging of large primary breast cancer with [18F]fluorodeoxyglucose positron emission tomography/computed tomography compared with conventional imaging procedures. J Clin Oncol 2008;26(29):4746–51. doi: 10.1200/JCO.2008.17.1496.

    Article  PubMed  Google Scholar 

  3. Gil-Rendo A, Zornoza G, Garcia-Velloso MJ, Regueira FM, Beorlegui C, Cervera M. Fluorodeoxyglucose positron emission tomography with sentinel lymph node biopsy for evaluation of axillary involvement in breast cancer. Br J Surg 2006;93(6):707–12. doi: 10.1002/bjs.5338.

    Article  CAS  PubMed  Google Scholar 

  4. van der Hoeven JJ, Hoekstra OS, Comans EF, Pijpers R, Boom RP, van Geldere D, et al. Determinants of diagnostic performance of [F-18]fluorodeoxyglucose positron emission tomography for axillary staging in breast cancer. Ann Surg 2002;236(5):619–24. doi: 10.1097/00000658-200211000-00012.

    Article  PubMed  Google Scholar 

  5. Veronesi U, De Cicco C, Galimberti VE, Fernandez JR, Rotmensz N, Viale G, et al. A comparative study on the value of FDG-PET and sentinel node biopsy to identify occult axillary metastases. Ann Oncol 2007;18(3):473–8. doi: 10.1093/annonc/mdl425.

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Affiliations

  1. Department of Nuclear Medicine, The Netherlands Cancer Institute/Antoni van Leeuwenhoek Hospital, Plesmanlaan 121, 1066 CX, Amsterdam, The Netherlands

    Tjeerd S. Aukema, Renato A. Valdés Olmos & Wouter V. Vogel

  2. Department of Surgery, The Netherlands Cancer Institute/Antoni van Leeuwenhoek Hospital, Amsterdam, The Netherlands

    Marieke E. Straver

Authors
  1. Tjeerd S. Aukema
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Marieke E. Straver
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Renato A. Valdés Olmos
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Wouter V. Vogel
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Wouter V. Vogel.

Additional information

An authors reply to this letter is available at http://dx.doi.org/10.1007/s00259-009-1209-7

Rights and permissions

Reprints and Permissions

About this article

Cite this article

Aukema, T.S., Straver, M.E., Valdés Olmos, R.A. et al. A different role for FDG PET/CT in axillary lymph node staging in breast cancer. Eur J Nucl Med Mol Imaging 36, 1896 (2009). https://doi.org/10.1007/s00259-009-1211-0

Download citation

  • Received:

  • Accepted:

  • Published:

  • DOI: https://doi.org/10.1007/s00259-009-1211-0

Keywords

  • Breast Cancer
  • Lymph Node
  • Breast Cancer Patient
  • Sentinel Lymph Node Biopsy
  • Axillary Lymph Node